Hasselbalch Hans Carl

52PUBLICATIONS
127CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)Predictive and prognostic markersHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Oct 07, 2026
CO-Rebreathing in Essential Thrombocythemia and Polycythemia Vera. A Revival of an Old Methodology to Improve Diagnosis and Phlebotomy Decisions.

|Sep 25, 2026
JAK2V617F Mutation in Ischemic Stroke: Bridging Hematology and Stroke Neurology.

|Sep 01, 2026
High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome.

|Aug 13, 2026
Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.

|Apr 08, 2026
A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alpha.

Richard T Silver, Hans Carl Hasselbalch

|Feb 26, 2026
Prime time for the use of statins in MPNs: from comorbidity drugs to disease-modifying partners.

Hans Carl Hasselbalch

Pageof 9

Frequent Collaborators

33 joint publications

Vibe Skov

22 joint publications

Lasse Kjaer

17 joint publications

Morten Kranker Larsen

16 joint publications

Ellervik Christina